Concepedia

Publication | Open Access

Two independent epigenetic biomarkers predict survival in neuroblastoma

DOIFull Paper Access

33

Citations

40

References

2015

Year

Yania Yáñez, Elena Grau, Virginia Rodríguez-Cortez, David Hervás, Enrique Vidal, Rosa Noguera, Miguel Ángel Ibáñez-Hernández, Vanessa Segura, Adela Cañete, Ana Conesa,
Clinical Epigenetics

Abstract

We found a new epigenetic signature predictive for NB patients' outcome: the methylation status of RB1 and TDGF1 associate with poorer survival. This information is useful to assess prognosis and improve treatment selection.

References

YearCitations

Page 1